ReviewClinical & developmental immunology2011
Toll-like receptor 4 activation in cancer progression and therapy.
Alja Oblak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
90 papers cite itlatest 60 shown
this paperpooled itcites it